Evidence map›Paper›PMID 10094392›Full record

ArticleMolecular and cellular biochemistry1999

Interactions of protein kinase CK2beta subunit within the holoenzyme and with other proteins.

M Kusk, R Ahmed, B Thomsen, C Bendixen, O G Issinger, B Boldyreff

Abstract read
PubMed
In one paragraph

Article in Molecular and cellular biochemistry, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Frontiers in neurology · 2022
    Article
  3. Article
  4. Review
  5. Casein kinase 2beta as a novel enhancer of activin-like receptor-1 signaling.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2009
    Article
  6. Review
  7. Ribosomal s6 kinase cooperates with casein kinase 2 to modulate the Drosophila circadian molecular oscillator.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2009
    Article
  8. Article
  9. Article
  10. Article
  11. Protein kinase CK2 as an ectokinase: the role of the regulatory CK2beta subunit.Proceedings of the National Academy of Sciences of the United States of America · 2008
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

M KuskBiokemisk Institut, Odense Universitet, Denmark.
R Ahmed
B Thomsen
C Bendixen
O G Issinger
B Boldyreff
Odense University Hospital · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protein kinase CK2 is a ubiquitous, highly conserved protein kinase with a tetrameric alpha2beta2 structure. For the formation of this tetrameric complex a beta-alpha dimer seems to be a prerequisite. Using the two-hybrid system and a series of CK2beta deletion mutants, we mapped domains involved in alpha-beta and beta-beta interactions. We also detected an intramolecular beta interaction within the amino acid stretch 132-165. Using CK2beta as a bait in a two-hybrid library screening several new putative cellular partners have been identified, among them the S6 kinase p90rsk, the putative tumor suppressor protein Doc-1, the Fas-associated protein FAF1, the mitochondrial translational initiation factor 2 and propionyl CoA carboxylase beta subunit.

Indexed as

Casein Kinase IIHoloenzymesHumansProtein BindingProtein Serine-Threonine KinasesRecombinant ProteinsCasein Kinase IIHoloenzymesProtein Serine-Threonine KinasesRecombinant Proteins

Identifiers

PMID10094392
OpenAlexW1511217235

What OpenQuestion holds

Texttitle and abstract
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.